Crinetics Pharmaceuticals, Inc.

CRNX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$110,901$53,726$94,569$264,545
Short-Term Investments$981,390$1,142,634$1,179,555$1,089,524
Receivables$0$0$7,314$8,470
Inventory$0$0$0$0
Other Curr. Assets$28,984$20,904$9,617$12,849
Total Curr. Assets$1,121,275$1,217,264$1,291,055$1,375,388
Property Plant & Equip (Net)$55,524$56,572$55,322$55,575
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$800$0$2,000
Tax Assets$0$0$0$0
Other NC Assets$19,232$14,938$14,950$1,629
Total NC Assets$74,756$72,310$70,272$59,204
Other Assets$0$0$0$0
Total Assets$1,196,031$1,289,574$1,361,327$1,434,592
Liabilities
Payables$6,109$11,325$9,842$5,853
Short-Term Debt$6,441$6,610$6,883$7,152
Tax Payable$0$0$0$0
Deferred Revenue$0$1,904$2,206$2,176
Other Curr. Liab.$61,605$48,557$38,380$44,503
Total Curr. Liab.$74,155$68,396$57,311$59,684
LT Debt$42,703$43,326$43,936$44,570
Deferred Rev, NC$0$3,992$4,313$4,704
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$7,004$2,334$1,767$829
Total NC Liab.$49,707$49,652$50,016$50,103
Other Liabilities$0$0$0$0
Cap. Leases$49,144$49,936$50,819$51,722
Total Liabilities$123,862$118,048$107,327$109,787
Equity
Pref Stock$0$0$0$0
Common Stock$2,364,699$2,334,538$2,300,882$2,275,952
Retained Earnings-$1,294,612-$1,164,521-$1,048,884-$952,110
AOCI$2,082$1,621$2,002$963
Other Equity$0-$112$0$0
Total Equity$1,072,169$1,171,526$1,254,000$1,324,805
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,196,031$1,289,574$1,361,327$1,434,592
Net Debt-$61,757-$3,790-$43,750-$212,823
Crinetics Pharmaceuticals, Inc. (CRNX) Financial Statements & Key Stats | AlphaPilot